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ABSTRACT	
The	replication	of	foot-and-mouth	disease	virus	(FMDV)	is	dependent	on	the	virus-encoded	3C	protease	(3Cpro).	As	in	other	picornaviruses,	3Cpro	performs	most	of	the	proteolytic	processing	of	the	polyprotein	expressed	from	the	single	open	reading	frame	in	the	RNA	genome	of	the	virus.	Previous	work	revealed	that	the	3Cpro	from	serotype	A	–	one	of	the	seven	serotypes	of	FMDV	–	adopts	a	trypsin-like	fold.	Phylogenetically	the	FMDV	serotypes	are	grouped	into	two	clusters,	with	O,	A,	C,	and	Asia	1	in	one,	and	the	three	South	African	Territories	serotypes,	(SAT-1,	SAT-2	and	SAT-3)	in	another.	We	report	here	the	cloning,	expression	and	purification	of	3C	proteases	from	four	SAT	serotype	viruses	(SAT2/GHA/8/91,	SAT1/NIG/5/81,	SAT1/UGA/1/97,	and	SAT2/ZIM/7/83)	and	the	crystal	structure	at	3.2	Å	resolution	of	3Cpro	from	SAT2/GHA/8/91).		
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INTRODUCTION	
Diseases	caused	by	RNA	viruses	are	often	difficult	to	control	because	of	the	high	mutation	rate	and	the	continual	emergence	of	novel	genetic	and	antigenic	variants	that	escape	from	immune	surveillance.	The	degree	to	which	immunity	induced	by	one	virus	is	effective	against	another	is	largely	dependent	on	the	antigenic	differences	between	them.	Foot-and-mouth	disease	virus	(FMDV)	is	an	example	of	an	antigenically	variable	pathogen	that	infects	many	species	of	cloven-hoofed	animals,	such	as	cattle,	sheep,	pigs	and	goats,	and	remains	a	potent	threat	to	agricultural	livestock	(Sutmoller	et	al.,	2003).	Although	FMD	vaccines	made	from	chemically	inactivated	virus	particles	are	in	widespread	use,	control	of	the	disease	remains	difficult.	This	is	because	the	vaccines	provide	only	short-lived	protection	and	the	virus	occurs	as	seven	clinically	indistinguishable	serotpyes	(O,	A,	C,	Asia1	and	three	South	African	Territories	serotypes:	SAT1,	SAT2	and	SAT3),	each	of	which	has	multiple,	constantly	evolving	sub-types	(Knowles	&	Samuel,	2003).	Viruses	belonging	to	the	SAT	serotypes	display	appreciably	greater	genomic	and	antigenic	variation	compare	to	serotype	A	and	O	viruses	(Bastos	et	al.,	2001;	Bastos	et	al.,	2003;	Maree	et	al.	2011),	possibly	due	to	their	long	term	maintenance	within	African	buffalo	(Syncerus	caffer).	Constant	surveillance	of	circulating	strains	is	required	to	ensure	that	vaccine	stocks	remain	effective.		
In	common	with	other	members	of	the	picornavirus	family,	FMDV	has	a	single-stranded,	positive-sense	RNA	genome	with	just	one	open	reading	frame.	Cell	entry	in	infected	hosts	is	followed	immediately	by	translation	of	the	viral	RNA,	which	yields	a	polyprotein	precursor	of	over	2,000	amino	acids	that	has	to	be	processed	into	fourteen	distinct	capsid	and	non-structural	proteins	for	virus	replication.	The	majority	of	this	processing	
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is	done	by	the	virus-encoded	3C	protease	(3Cpro),	which	cleaves	the	precursor	at	ten	distinct	sites	(reviewed	in	Curry	et	al.,	2007).		
Crystallographic	analysis	of	the	3Cpro	from	a	type	A	FMDV	(sub-type	A1061)	showed	that,	similar	to	other	picornavirus	3C	proteases,	it	adopts	a	trypsin-like	fold	consisting	of	two	
β-barrels	that	pack	together	to	create	a	centrally-located	Cys-His-Asp/Glu	catalytic	triad	in	the	active	site	(Allaire	et	al.,	1994;	Matthews	et	al.,	1994;	Mosimann	et	al.,	1997;	Birtley	et	al.,	2005;	Yin	et	al.,	2005).	Subsequent	studies	on	FMDV	3Cpro	complexed	with	peptides	derived	from	the	viral	polyprotein	work	revealed	that	substrate	recognition	is	achieved	by	conformational	changes	primarily	involving	the	movement	of	a	β-ribbon	(residues	138-150)	that	helps	to	secure	the	position	of	cognate	peptides	in	relation	to	the	active	site	of	the	protein	(Sweeney	et	al.,	2007;	Zunszain	et	al.,	2010).		
Mapping	of	the	sequence	variation	between	different	FMDV	serotypes	onto	the	structure	of	A1061	3Cpro	indicated	that	the	peptide-binding	face	of	the	protease	is	completely	conserved	among	the	non-SAT	serotypes	(which	are	91-97%	conserved	in	amino-acid	sequence),	supporting	the	notion	that	identification	of	inhibitors	of	the	protease	might	aid	the	development	of	broad	spectrum	antiviral	drugs	(Birtley	et	al.,	2005;	Curry	et	al.,	2007).	This	structure	should	therefore	serve	as	a	useful	model	for	the	3C	protease	from	this	group	of	viruses.	However,	the	same	comparison	suggested	the	presence	of	at	least	two	amino	acid	differences	on	the	peptide-binding	surfaces	between	A1061	3Cpro	and	the	corresponding	3C	sequences	from	SAT	serotype	viruses.		
To	provide	a	more	complete	picture	of	the	structural	variation	between	FMDV	3C	proteases	from	different	serotypes,	we	set	out	to	determine	the	crystal	structure	of	3Cpro	from	at	least	one	SAT	serotype	virus.	We	report	here	the	cloning	and	expression	of	3Cpro	
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from	four	distinct	SAT1	and	SAT2	viruses	and	the	crystal	structure	of	the	3Cpro	from	a	SAT2	serotype	virus	(SAT2/GHA/8/91).		
	
MATERIALS	AND	METHODS	
Cloning	and	mutagenesis:	We	used	the	polymerase	chain	reaction	(PCR)	to	amplify	the	coding	regions	for	the	FMDV	3C	proteases	of	sub-types	SAT2/GHA/8/91	(Accession	No.	AY884136),	SAT1/NIG/5/81	(Accession	No.	AY882592),	SAT1/UGA/1/97	(Accession	No.	AF283456),	and	SAT2/ZIM/7/83	(Accession	No.	AF540910).	In	each	case	the	reaction	was	performed	using	DNA	primers	(Table	1)	that	introduced	5´	XhoI	and	a	3´	
HindIII	restriction	sites	into	the	PCR	products.	These	served	to	facilitate	ligation	into	a	version	of	the	pETM-11	vector	that	had	been	modified	to	insert	a	thrombin	cleavage	site	immediately	downstream	of	the	N-terminal	His	tag	(Birtley	&	Curry,	2005).	DNA	ligations	were	performed	using	the	Roche	Rapid	Ligation	Kit	according	to	the	manufacturer’s	instructions.		
Site-directed	mutagenesis	was	performed	with	the	Quikchange	method	(Stratagene),	using	KOD	polymerase	(Novagen).	All	DNA	sequences	were	verified	by	sequencing.		
Protein	Expression	and	Purification:	All	SAT-type	3C	proteases	were	expressed	in	cultures	of	BL21	(DE3)	pLysS	E.	coli	(Invitrogen)	grown	in	lysogeny	broth	(LB)	at	37°C	with	shaking	at	225	rpm.	Protein	expression	was	induced	for	5	hours	by	the	addition	of	1	mM	isopropyl	β-d-1-thiogalactopyranoside	(IPTG)	once	the	optical	density	at	600	nm	reached	0.8-1.0.	Cells	were	harvested	by	centrifugation	at	4550	g	for	15	min	at	4°C	and	frozen	at	–80	°C.		
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The	volumes	given	below	are	appropriate	for	processing	the	pellet	from	1	L	of	bacterial	culture.	Cell	pellets	were	thawed	on	ice	and	re-suspended	in	30	mL	Buffer	A	(50	mM	HEPES	pH7.1,	400	mM	NaCl,	1	mM	β-mercaptoethanol)	supplemented	with	0.1%	Triton	X-100	and	1	mM	phenylmethylsulfonyl	fluoride	(PMSF)	protease	inhibitor.	Cells	were	lysed	by	sonication	on	ice	and	lysates	clarified	by	centrifugation	at	29,000	g	for	20	min	at	4°C.	Protamine	Sulphate	(Sigma)	was	added	to	1	mg/ml	final	concentration	to	precipitate	nucleic	acids,	and	lysates	were	then	centrifuged	again	at	29,000	g	for	20	min.	The	supernatant	was	filtered	using	a	1.2	μm	syringe	filter	and	incubated	for	90	minutes	at	4°C	with	slow	rotation	in	1	mL	bed	volume	of	TALON	metal	affinity	resin	(Clontech)	pre-equilibrated	with	buffer	A.	This	slurry	was	applied	to	a	gravity-flow	column	and	the	TALON	beads	washed	three	times	with	50	mL	of	Buffer	A	supplemented	with	0,	5	and	10	mM	imidazole	respectively.	His-tagged	3C	proteins	were	eluted	in	20	ml	of	Buffer	A	containing	100	mM	imidazole,	followed	by	a	final	wash	with	10	ml	of	Buffer	A	containing	250	mM	imidazole.	To	remove	the	His	tag	the	eluted	protein	was	mixed	with	100	units	of	bovine	thrombin	(Sigma)	and	dialysed	for	16	hr	at	4°C	in	4	L	of	Buffer	A	supplemented	with	2	mM	CaCl2.	Cleaved	protein	was	then	re-applied	to	TALON	resin	to	remove	the	cleaved	His	tag	and	other	contaminants.	The	untagged	protease	was	recovered	in	the	flow	through,	concentrated	using	Vivaspin	concentraters	(3	kD	MWCO)	(Sartorius	Stedim	Biotech)	and	further	purified	by	gel	filtration	using	HiLoad	16/60	Superdex	75	gel	filtration	column	(Amersham	Bioscience)	in	Buffer	A	supplemented	with	1	mM	EDTA	and	0.01%	sodium	azide	at	flow	rate	of	0.5	ml/min.	Peak	fractions	were	pooled,	concentrated	and	stored	at	–80	°C.	Protein	concentrations	were	determined	from	absorbance	measurements	at	280	nm	using	extinction	coefficients	calculated	with	the	ProtParam	tool	(Gastiger	et	al.,	2005).	
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Crystallisation	and	structure	determination:	Crystallisation	trials	with	purified	SAT-type	3Cpro	were	performed	at	4°C	and	18°C	using	protein	concentrations	in	the	range	5-10	mg/mL.	Initial	screens	were	done	by	sitting	drop	vapour	diffusion	using	a	Mosquito	crystallisation	robot	(TTP	Labtech).	Typically	in	each	drop	100	nl	of	protein	was	mixed	with	100nl	taken	from	the	100	µL	reservoir	solution.	Trials	were	performed	with	the	following	commercial	screens:	Crystal	screen	1	and	2,	and	PEG/Ion	(Hampton	Research);	Memstart,	Memcys,	JCSG+,	and	PACT	(Molecular	Dimensions);	Wizard	1	and	2	(Rigaku	Reagents).	
Crystals	of	g3C-SAT2-G(1-208)	for	data	collection	were	washed	in	the	mother	liquor	(15%	(w/v)	PEG-8000,	0.09	M	Na-cacodylate	pH	7.0,	0.27	M	Ca-acetate,	0.01	M	Tris	pH	8.5,	0.08	M	Na-thiocyanate)	supplemented	with	20%	(v/v)	glycerol,	and	immediately	frozen	in	liquid	nitrogen	in	a	nylon	loop.	X-ray	diffraction	data	were	processed	and	scaled	with	the	CCP4	program	suite	(Collaborative	Computer	Project	No.	4,	1994),	and	phased	by	molecular	replacement	using	the	coordinates	of	type	A1061	FMDV	3Cpro	(PDB	ID	2j92;	(Sweeney	et	al.,	2007))	as	a	search	model	in	Phaser	(McCoy	et	al.,	2007).	The	search	model	was	edited	to	delete	side-chains	(to	the	Cβ	atom)	for	all	residues	that	differed	with	g3C-SAT2-G(1-208)	and	to	remove	all	the	atoms	in	the	β-ribbon	(residues	138-150),	since	these	have	been	observed	to	vary	in	structure	between	different	crystal	forms	(Sweeney	et	al.,	2007).	Model	building	and	adjustments	were	done	using	Coot	(Emsley	et	al.,	2010);	crystallographic	refinement	was	performed	initially	with	CNS	(Brünger	et	al.,	1998)	and	completed	using	Phenix	(Adams	et	al.,	2010).		
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RESULTS	AND	DISCUSSION	
Protein	expression	and	crystallisation:	We	engineered	bacterial	expression	plasmids	for	FMDV	3C	proteases	from	four	SAT	sub-types:	SAT2/GHA/8/91,	SAT1/NIG/5/81,	SAT1/UGA/1/97,	and	SAT2/ZIM/7/83	(see	Materials	and	Methods).	In	doing	so	we	were	guided	by	the	lessons	learned	from	work	to	express	and	crystallise	subtype	A1061	FMDV	3Cpro,	which	suggested	that	preserving	the	N	terminus	of	the	protein	but	truncating	the	C	terminus	by	up	to	six	residues	would	be	optimal	for	solubility	and	crystallisation	(Birtley	&	Curry,	2005).	Accordingly,	for	each	SAT	sub-type	we	generated	expression	constructs	that	add	a	thrombin-cleavable	His	tag	to	the	N	terminus	of	residues	1-208	of	the	213	amino	acid	3C	protease;	following	thrombin	cleavage	there	is	a	single	additional	Gly	residue	appended	to	the	N	terminus	of	the	protease	polypeptide.	To	ensure	the	solubility	of	the	SAT-type	3C	proteins,	we	introduced	to	all	constructs	a	C142A	substitution	to	remove	a	surface-exposed	Cys	that	had	been	shown	previously	to	be	responsible	for	protein	aggregation	(Birtley	&	Curry,	2005;	Birtley	et	al.,	2005).	(The	C95K	mutation	also	introduced	to	eliminate	aggregation	of	A1061	FMDV	3Cpro	(Birtley	&	Curry,	2005)	was	not	needed	here	because	residue	95	is	an	Arg	in	the	SAT	3C	proteases	used	in	this	study).	In	addition,	the	active	site	nucleophile	was	eliminated	from	all	constructs	by	incorporation	of	a	C163A	substitution	to	prevent	adventitious	proteolysis	in	highly	concentrated	samples	of	purified	3Cpro.	For	consistency	with	our	earlier	naming	scheme	these	SAT2/GHA/8/91,	SAT1/NIG/5/81,	SAT1/UGA/1/97,	and	SAT2/ZIM/7/83	3C	constructs	will	be	referred	to	as	SAT2/G-g3Cpro(1-208),	SAT1/N-g3Cpro(1-208),	SAT1/U-	g3Cpro(1-208),	and	SAT2/Z-	g3Cpro(1-208)	respectively.		
The	3Cpro	proteins	from	all	four	SAT	sub-types	yielded	soluble	protein	that	was	purified	first	by	metal-affinity	chromatography	and	them	following	thrombin	cleavage	of	the	
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N-terminal	His	tag,	on	a	gel	filtration	column	(see	Materials	and	Methods).	Of	the	four,	SAT1/N-g3Cpro(1-208)	appeared	to	be	the	most	soluble	and	could	be	concentrated	to	20	mg/mL.	The	other	three	variants	exhibited	some	precipitation	during	gel	filtration,	indicated	by	a	void	peak	containing	aggregated	3Cpro,	which	was	about	one-third	of	the	area	of	the	monomeric	peak.	They	also	had	lower	apparent	solubility	limits	and	could	be	concentrated	to	~6	mg/mL	[SAT2/G-g3Cpro(1-208)]	or	~11	mg/mL	[SAT1/U-	g3Cpro(1-208),	and	SAT2/Z-	g3Cpro(1-208)].		
In	crystallisation	trials	we	only	obtained	crystals	from	the	3Cpro	of	a	single	sub-type:	SAT2/G-g3Cpro(1-208).	These	exhibited	a	variety	of	habits	but	the	largest	were	needle-shaped	and	were	typically	10	µm	wide	and	up	to	300	µm	long.	In	initial	diffraction	tests	on	beamline	ID23-2	at	the	European	Synchrotron	Radiation	Facility	(ESRF)	showed	that	the	crystals	belonged	to	a	trigonal	spacegroup	and	diffracted	to	a	resolution	limit	of	2	Å.	Unfortunately,	for	reasons	that	remain	unclear,	efforts	to	reproduce	these	crystals	proved	troublesome.	In	subsequent	trials	diffraction	was	limited	to	~3	Å.		
We	used	mutagenesis	to	engineer	modifications	to	the	SAT2/G-g3Cpro(1-208)	construct	in	the	search	for	better	crystals.	Although	alterations	to	trim	the	C-terminus	by	one	residue	[in	SAT2/G-g3Cpro(1-207)],	or	to	add	back	a	single	His	residue	[in	SAT2/G-g3Cpro(1-207h)]	–	strategies	that	had	been	useful	when	working	with	type	A1061	3Cpro	(Birtley	&	Curry,	2005)	—	both	yielded	soluble	protein	and	SAT2/G-g3Cpro(1-207h)	produced	crystals,	there	was	no	improvement	in	the	resolution	of	the	diffraction.		
In	a	further	effort	to	enhance	crystal	quality,	we	used	the	Surface	Entropy	Reduction	prediction	server	(Goldschmidt	et	al.,	2007)	to	design	additional	SAT2/G-g3Cpro(1-208)	mutants.	We	made	four	different	mutants,	each	containing	the	following	pairs	of	substitutions:	(i)	K110T/K111Y	(ii)	K110Y/K111T;	(iii)	K51A/K54Y;	(iv)	K51T/K54S.	Of	
Crystal structure of FMDV SAT-type 3C protease  18/02/2016 
 10 
these,	only	the	K51A/K54Y	mutant	gave	protein	that	was	as	soluble	as	wild-type.	The	K110T/K111Y	and	K51T/K54S	double-mutants	produced	significantly	larger	void	peaks	during	purification	by	gel	filtration	chromatography,	while	the	K110Y/K111T	double-mutant	appeared	almost	entirely	aggregated	under	these	conditions.	For	the	three	surface-entropy	mutants	that	did	yield	soluble	protein,	no	useable	crystals	were	obtained.		
Structure	of	SAT2/G-g3Cpro(1-208):	A	complete	dataset	to	3.2	Å	resolution	was	obtained	from	crystals	of	SAT2/G-g3Cpro(1-208).	The	crystals	belong	to	space-group	P32	and	have	a	long	c-axis	(318.5	Å).	The	diffraction	data	were	phased	by	molecular	replacement	using	a	search	model	based	on	the	crystal	structure	of	type	A1061	FMDV	3Cpro,	which	is	80%	identical	in	amino-acid	sequence	to	SAT2/G-g3Cpro(1-208)	(see	Materials	and	Methods).	This	gave	an	unambiguous	solution	with	a	log	likelihood	gain	of	1495	(McCoy	et	al.,	2007),	revealing	five	molecules	in	the	asymmetric	unit.	Though	of	modest	resolution,	the	initial	electron	density	maps	were	of	sufficient	quality	to	guide	adjustment	of	the	initial	molecular	replacement	model	prior	to	multiple	interleaved	rounds	of	refinement	and	model	building	(Fig.	1a).	Because	of	the	limited	resolution	and	non-crystallographic	symmetry,	refinement	was	performed	using	group	B-factors	and	non-crystallographic	restraints.	Model	building	was	done	conservatively	–	amino	acid	side-chains	were	truncated	to	the	Cβ	atom	in	cases	where	there	was	no	indicative	electron	density.	The	final	model	of	SAT2/G-g3Cpro(1-208)	contains	residues	7-207	for	all	five	chains	and	has	an	Rfree	of	27.2%	and	good	stereochemistry;	full	data	collection	and	refinement	statistics	are	given	in	Table	1.	
As	expected,	given	the	high	level	of	amino	acid	sequence	identity	with	A1061	3Cpro,	FMDV	SAT2/G-g3Cpro(1-208)	adopts	the	same	trypsin-like	fold	(Fig.	1b),	which	has	been	
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described	in	detail	elsewhere	(Birtley	et	al.,	2005;	Sweeney	et	al.,	2007).	Superposition	of	the	five	molecules	in	the	asymmetric	unit	shows	that	they	are	highly	similar	to	one	another	(Fig.	1c)	–	the	pair-wise	root	mean	square	deviation	in	Cα	positions	between	chains	is	0.2-0.3	Å.	The	largest	differences	are	observed	in	the	longest	surface-exposed	loops,	the	E1-F1	loop	in	the	N-terminal	β-barrel	and	the	B2-C2	loop	known	as	the	
β-ribbon	in	the	C-terminal	β-barrel	(Fig.	1c).	These	are	also	the	regions	of	greatest	difference	between	SAT2/G-g3Cpro(1-208)	and	A1061	3Cpro;	(overlay	of	the	two	structures	yields	an	overall	rms	deviation	in	Cα	positions	of	~0.6	Å)	(Fig.	1d).	The	flexibility	of	the	β-ribbon,	which	shifts	in	position	to	aid	peptide	binding,	has	been	noted	before	(Zunszain	et	al.,	2010)	and	clearly	it	plays	a	similar	role	in	SAT-type	3C	proteases.		
	
CONCLUDING	REMARKS	
The	results	reported	here	provide	a	template	structure	of	a	SAT-type	FMDV	3C	protease	that	should	be	of	value	in	directing	molecular	investigations	of	this	group	of	proteases.	Although	it	is	frustrating	that	higher-resolution	diffraction	data	were	not	obtained,	given	that	initial	crystals	of	SAT2/G-g3Cpro(1-208)	diffracted	to	2	Å,	this	should	be	possible	with	further	optimization.	Likewise,	since	soluble	3Cpro	was	found	to	be	purified	from	three	other	SAT-type	viruses	–	notably	SAT1/NIG/5/81	–	crystal	structures	for	these	proteases	may	well	also	be	achievable.	This	work	has	applications	in	the	use	of	reverse	genetics	approaches	or	the	design	of	empty	virus	capsids	to	target	antigenically	significant	subtypes	in	the	design	of	regional	vaccines	for	the	control	of	FMD	(Porta	et	al.,	2013).	
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FIGURE	
	
Figure	1:	Structure	of	the	3C	protease	from	the	SAT2/GHA/8/91	serotype	FMDV.		(a)	Section	of	the	3.2	Å	resolution	electron	density	map	(blue	chicken	wire)	calculated	with	phases	from	the	final	refined	model,	which	is	shown	as	sticks	coloured	by	atom	type:	grey	–	carbon;	red	–	oxygen;	blue	–	nitrogen;	yellow	–	sulphur.	(b)	Overall	structure	of	SAT2/G-g3Cpro(1-208),	with	secondary	structure	elements	indicated.	(c)	Superposition	of	the	five	molecules	of	SAT2/G-g3Cpro(1-208)	in	the	asymmetric	unit	of	the	crystal,	shown	in	ribbon	representation.	(d)	Comparative	superposition	of	SAT2/G-g3Cpro(1-208)	(teal)	with	A1061	3Cpro	in	the	absence	(purple;	PDB	2J92))	and	presence	(orange;	PDB	2WV4))	of	a	peptide	substrate	(shown	in	stick	representation).			 	
Crystal structure of FMDV SAT-type 3C protease  18/02/2016 
 16 
TABLE	1:	DNA	primers	for	cloning	and	mutagenesis	
	Forward	Reverse	C142A-for	C142A-rev	C163A-for	C163Arev	
SAT2/GHA/8/91		GATGATCTCGAGGAAGTGGCGCTCCGCCGACCGAC	CATGCCAAGCTTATGGGTCAATGTGTGCTTTGAGTTGGAGCAGGCTCGACCGTG	GGACCAAGGTTGGATACGCTGGAGGAGCCGTCATGAC	GTCATGACGGCTCCTCCAGCGTATCCAACCTTGGTCC	CATACAAAGATGTTGTCGTCGCCATGGACGGTGAACACCATGC	GCATGGTGTCACCGTCCATGGCGACGACAACATCTTTGTATG		Forward	Reverse	C142A-for	C142A-rev	C163A-for	C163Arev	
SAT1/NIG/5/81	GATGATCTCGAGGAAGTGGAGCGCCACCCACCGAC	CATGCCAAGCTTAAGGGTCGATGTGTGCCTTCATC	GCCACCAAAGCTGGTTACGCTGGAGGAGCCGTTCTTG	CAAGAACGGCTCCTCCAGCGTAACCAGCTTTGGTGGC	CCTACAAAGACATCGTAGTGGCTATGGATGGTGACACCATGC	GCATGGTGTCACCATCCATAGCCACTACGATGTCTTTTGTAGG		Forward	Reverse	C142A-for	C142A-rev	C163A-for	C163Arev	
SAT1/UGA1/97	GATGATCTCGAGGAAGCGGTGCGCCACCGACCGAC	CATGCCAAGCTTATGGGTCGATGTGGGCTTTCATC	GGACCAAGGTAGGTTACGCTGGGGCGGCCGTACTGAC	GTCAGTACGGCCGCCCCAGCGTAACCTACCTTGGTCC	GTACAACGACATCGTCGTCGCCATGGACGGCGACACCATG	CATGGTGTCGCCGTCCATGGCGACGACGATGTCGTTGTAC		Forward	Reverse	C142A-for	C142A-rev	C163A-for	C163Arev	
SAT2/ZIM/7/83	GATGATCTCGAGGAAGCGGAGCCCCACCGACCGAC	CATGCCAAGCTTAAGGGTCGATGTGGGCCTTCATC		GGGACCAAAGTTGGATACGCTGGAGCCGCTGTTCTCG	CGAGAACAGCGGCTCCAGCGTATCCAACTTTGGTCCC	CCTACAAAGACCTAGTCGTTGCTATGGACGGTGACACCATGC	GCATGGTGTCACCGTCCATAGCAACGACTAGGTCTTTGTAGG		
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TABLE	2:	Crystallographic	data	collection	and	model	refinement	statistics	for	SAT2	3Cpro.		
DATA	COLLECTION	
Space-group	 P32	
a,	b,	c	(Å)	 54.0,	54.0,	318.5	
α,	β,	γ	(°)	 α	=	β	=	90;	γ	=	120	
Resolution	range	(Å)	 53.1-3.2	(3.37-3.2)	
No.	of	independent	reflections	 17053	
Multiplicity1	 2.7	(2.7)	
Completeness	(%)	 99.3	(99.5)	
I/σI		 5.7	(1.7)	
Rmerge	(%)2	 11.6	(42.4)	
	 	MODEL	REFINEMENT	
No.	of	Non-hydrogen	atoms	 7535	
Rwork	(%)3	 22.2	
Rfree	(%)4	 27.2	
Average	B-factor	(Å2)	 119	
RMS	deviations	-	Bonds	(Å)	5	 0.006	
RMS	deviations	-	Angles	(°)	 1.1	
Ramachandran	plot	(favoured/allowed)	%	 89.8/10.2	
PDB	Accession	Code	 4X2Y		
1Values	for	highest	resolution	shell	given	in	parentheses		
2Rmerge	=	100 ×Σhkl|Ij(hkl)	−	<Ij(hkl)>|/	ΣhklΣjI(hkl),	where	Ij(hkl)	and	<Ij(hkl)>	are	the	intensity	of	measurement	j	and	the	mean	intensity	for	the	reflection	with	indices	hkl,	respectively.	
3Rwork	=	100 ×Σhkl||Fobs|	−	|Fcalc||/Σhkl|Fobs|.	
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4Rfree	is	the	Rmodel	calculated	using	a	randomly	selected	5%	sample	of	reflection	data	that	were	omitted	from	the	refinement.	
5RMS,	root-mean-square;	deviations	are	from	the	ideal	geometry	defined	by	the	Engh	and	Huber	parameters	(Engh	&	Huber,	1991).	
	
